|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang W, Hong L, Xu X, Wang Q, Huang J and
Jiang L: LncRNA GAS5 suppresses the tumorigenesis of cervical
cancer by downregulating miR-196a and miR-205. Tumour Biol.
39:10104283177113152017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dryden-Peterson S, Bvochora-Nsingo M,
Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D,
Kebabonye-Pusoentsi M, Clayman R, Mapes AC, et al: HIV infection
and survival among women with cervical cancer. J Clin Oncol.
34:3749–3757. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chuang LT, Feldman S, Nakisige C, Temin S
and Berek JS: Management and care of women with invasive cervical
cancer. J Clin Oncol. 34:3354–3355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perez DS, Hoage TR, Pritchett JR,
Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS and
Smith DI: Long, abundantly expressed non-coding transcripts are
altered in cancer. Hum Mol Genet. 17:642–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattick JS: The functional genomics of
noncoding RNA. Science. 309:1527–1528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lanz RB, McKenna NJ, Onate SA, Albrecht U,
Wong J, Tsai SY, Tsai MJ and O'Malley BW: A steroid receptor
coactivator, SRA, functions as an RNA and is present in an SRC-1
complex. Cell. 97:17–27. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ling H, Vincent K, Pichler M, Fodde R,
Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long
non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leygue E: Steroid receptor RNA activator
(SRA1): Unusual bifaceted gene products with suspected relevance to
breast cancer. Nucl Recept Signal. 5:e0062007.PubMed/NCBI
|
|
14
|
Colley SM and Leedman PJ: Steroid receptor
RNA activator-A nuclear receptor coregulator with multiple
partners: Insights and challenges. Biochimie. 93:1966–1972. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eoh KJ, Paek J, Kim SW, Kim HJ, Lee HY,
Lee SK and Kim YT: Long non-coding RNA, steroid receptor RNA
activator (SRA), induces tumor proliferation and invasion through
the NOTCH pathway in cervical cancer cell lines. Oncol Rep.
38:3481–3488. 2017.PubMed/NCBI
|
|
16
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hall PA and Russell SH: New perspectives
on neoplasia and the RNA world. Hematol Oncol. 23:49–53. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
25
|
Ramis-Conde I, Chaplain MA, Anderson AR
and Drasdo D: Multi-scale modelling of cancer cell intravasation:
The role of cadherins in metastasis. Phys Biol. 6:0160082009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calaf GM, Balajee AS, Montalvo-Villagra
MT, Leon M, Daniela NM, Alvarez RG, Roy D, Narayan G and
Abarca-Quinones J: Vimentin and Notch as biomarkers for breast
cancer progression. Oncol Lett. 7:721–727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin TA, Goyal A, Watkins G and Jiang
WG: Expression of the transcription factors snail, slug, and twist
and their clinical significance in human breast cancer. Ann Surg
Oncol. 12:488–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Delgado G, Bundy B, Zaino R, Sevin BU,
Creasman WT and Major F: Prospective surgical-pathological study of
disease-free interval in patients with stage IB squamous cell
carcinoma of the cervix: A Gynecologic Oncology Group study.
Gynecol Oncol. 38:352–357. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wentz WB and Reagan JW: Survival in
cervical cancer with respect to cell type. Cancer. 12:384–388.
1959. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biewenga P, van der Velden J, Mol BW,
Stalpers LJ, Schilthuis MS, van der Steeg JW, Burger MP and Buist
MR: Prognostic model for survival in patients with early stage
cervical cancer. Cancer. 117:768–776. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kodama J, Seki N, Masahiro S, Kusumoto T,
Nakamura K, Hongo A and Hiramatsu Y: Prognostic factors in stage
IB-IIB cervical adenocarcinoma patients treated with radical
hysterectomy and pelvic lymphadenectomy. J Surg Oncol. 101:413–417.
2010.PubMed/NCBI
|
